- Home
- FTHM vs AKTX Comparison
FTHM vs AKTX Comparison
Compare FTHM & AKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- AKTX
- Stock Information
- Founded
- FTHM 2010
- AKTX N/A
- Country
- FTHM United States
- AKTX United States
- Employees
- FTHM N/A
- AKTX N/A
- Industry
- FTHM Real Estate
- AKTX Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- AKTX Health Care
- Exchange
- FTHM Nasdaq
- AKTX Nasdaq
- Market Cap
- FTHM 27.1M
- AKTX 24.5M
- IPO Year
- FTHM 2020
- AKTX N/A
- Fundamental
- Price
- FTHM $0.78
- AKTX $1.13
- Analyst Decision
- FTHM Strong Buy
- AKTX
- Analyst Count
- FTHM 4
- AKTX 0
- Target Price
- FTHM $4.25
- AKTX N/A
- AVG Volume (30 Days)
- FTHM 87.0K
- AKTX 28.3K
- Earning Date
- FTHM 03-12-2025
- AKTX 05-15-2025
- Dividend Yield
- FTHM N/A
- AKTX N/A
- EPS Growth
- FTHM N/A
- AKTX N/A
- EPS
- FTHM N/A
- AKTX N/A
- Revenue
- FTHM $335,184,000.00
- AKTX N/A
- Revenue This Year
- FTHM $26.16
- AKTX N/A
- Revenue Next Year
- FTHM $23.48
- AKTX N/A
- P/E Ratio
- FTHM N/A
- AKTX N/A
- Revenue Growth
- FTHM N/A
- AKTX N/A
- 52 Week Low
- FTHM $0.70
- AKTX $0.85
- 52 Week High
- FTHM $3.37
- AKTX $4.40
- Technical
- Relative Strength Index (RSI)
- FTHM 31.89
- AKTX 55.37
- Support Level
- FTHM $0.70
- AKTX $1.24
- Resistance Level
- FTHM $0.99
- AKTX $1.56
- Average True Range (ATR)
- FTHM 0.08
- AKTX 0.12
- MACD
- FTHM 0.01
- AKTX 0.01
- Stochastic Oscillator
- FTHM 17.65
- AKTX 45.26
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title.
About AKTX Akari Therapeutics plc ADS
Akari Therapeutics PLC is a clinical stage biopharmaceutical company. It is focused on developing therapies for autoimmune and inflammatory diseases involving the complement component 5 (C5) and leukotriene B4 (LTB4) pathways. The company's pipelines include HSCT-TMA and Geographic Atrophy (GA).